These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35018531)

  • 1. The diagnostic value of contrast enhancement on MRI in diffuse and anaplastic gliomas.
    Krigers A; Demetz M; Grams AE; Thomé C; Freyschlag CF
    Acta Neurochir (Wien); 2022 Aug; 164(8):2035-2040. PubMed ID: 35018531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age is associated with unfavorable neuropathological and radiological features and poor outcome in patients with WHO grade 2 and 3 gliomas.
    Krigers A; Demetz M; Thomé C; Freyschlag CF
    Sci Rep; 2021 Aug; 11(1):17380. PubMed ID: 34462493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
    Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
    J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast enhancement is a prognostic factor in IDH1/2 mutant, but not in wild-type WHO grade II/III glioma as confirmed by machine learning.
    Suchorska B; Schüller U; Biczok A; Lenski M; Albert NL; Giese A; Kreth FW; Ertl-Wagner B; Tonn JC; Ingrisch M
    Eur J Cancer; 2019 Jan; 107():15-27. PubMed ID: 30529899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The advanced development of Cx43 and GAP-43 mediated intercellular networking in IDH1 wildtype diffuse and anaplastic gliomas with lower mitotic rate.
    Krigers A; Moser P; Fritsch H; Demetz M; Brawanski K; Thomé C; Freyschlag CF
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):3003-3009. PubMed ID: 34173871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
    Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
    Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.
    Wang YY; Wang K; Li SW; Wang JF; Ma J; Jiang T; Dai JP
    AJNR Am J Neuroradiol; 2015 Nov; 36(11):2023-9. PubMed ID: 26316565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninvasively evaluating the grading and IDH1 mutation status of diffuse gliomas by three-dimensional pseudo-continuous arterial spin labeling and diffusion-weighted imaging.
    Liu T; Cheng G; Kang X; Xi Y; Zhu Y; Wang K; Sun C; Ye J; Li P; Yin H
    Neuroradiology; 2018 Jul; 60(7):693-702. PubMed ID: 29777252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volume-based histogram analysis of dynamic contrast-enhanced MRI for estimation of gliomas IDH1 mutation status.
    Hu Y; Zhang N; Yu MH; Zhou XJ; Ge M; Shen DD; Hua Y; Shi JL; Jia ZZ
    Eur J Radiol; 2020 Oct; 131():109247. PubMed ID: 32891974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Same but different. Incidental and symptomatic lower grade gliomas show differences in molecular features and survival.
    Demetz M; Krigers A; Moser P; Kerschbaumer J; Thomé C; Freyschlag CF
    J Neurooncol; 2023 Apr; 162(2):397-405. PubMed ID: 37043120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic Gliomas.
    Hong JB; Roh TH; Kang SG; Kim SH; Moon JH; Kim EH; Ahn SS; Choi HJ; Cho J; Suh CO; Chang JH
    Cancer Res Treat; 2020 Oct; 52(4):1041-1049. PubMed ID: 32324987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Histopathology and Magnetic Resonance Imaging Texture in Grading Gliomas Based on Intraoperative Magnetic Resonance Navigated Stereotactic Biopsy.
    Rui W; Pang H; Xie Q; Wang Y; Duan S; Ren Y; Yao Z
    J Comput Assist Tomogr; 2021 Sep-Oct 01; 45(5):728-735. PubMed ID: 34347700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined texture analysis of diffusion-weighted imaging with conventional MRI for non-invasive assessment of IDH1 mutation in anaplastic gliomas.
    Su CQ; Lu SS; Zhou MD; Shen H; Shi HB; Hong XN
    Clin Radiol; 2019 Feb; 74(2):154-160. PubMed ID: 30391048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas.
    Leu K; Ott GA; Lai A; Nghiemphu PL; Pope WB; Yong WH; Liau LM; Cloughesy TF; Ellingson BM
    J Neurooncol; 2017 Aug; 134(1):177-188. PubMed ID: 28547590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [IDH1/2 mutations in gliomas].
    Nobusawa S; Yokoo H
    Brain Nerve; 2011 Dec; 63(12):1378-86. PubMed ID: 22147457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ATRX immunostaining predicts IDH and H3F3A status in gliomas.
    Ebrahimi A; Skardelly M; Bonzheim I; Ott I; Mühleisen H; Eckert F; Tabatabai G; Schittenhelm J
    Acta Neuropathol Commun; 2016 Jun; 4(1):60. PubMed ID: 27311324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status.
    Grabner G; Kiesel B; Wöhrer A; Millesi M; Wurzer A; Göd S; Mallouhi A; Knosp E; Marosi C; Trattnig S; Wolfsberger S; Preusser M; Widhalm G
    Eur Radiol; 2017 Apr; 27(4):1556-1567. PubMed ID: 27300198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of GAP-43, Cx43 and actin expression on the outcome and overall survival in diffuse and anaplastic gliomas.
    Krigers A; Demetz M; Moser P; Kerschbaumer J; Brawanski KR; Fritsch H; Thomé C; Freyschlag CF
    Sci Rep; 2023 Feb; 13(1):2024. PubMed ID: 36739296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplified perfusion fraction from diffusion-weighted imaging in preoperative prediction of IDH1 mutation in WHO grade II-III gliomas: comparison with dynamic contrast-enhanced and intravoxel incoherent motion MRI.
    Wang X; Cao M; Chen H; Ge J; Suo S; Zhou Y
    Radiol Oncol; 2020 Jun; 54(3):301-310. PubMed ID: 32559177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas.
    Hartmann C; Meyer J; Balss J; Capper D; Mueller W; Christians A; Felsberg J; Wolter M; Mawrin C; Wick W; Weller M; Herold-Mende C; Unterberg A; Jeuken JW; Wesseling P; Reifenberger G; von Deimling A
    Acta Neuropathol; 2009 Oct; 118(4):469-74. PubMed ID: 19554337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.